Monday, June 1, 2026

North Korea vs. Qatar World Cup Qualifier Moved to Laos Amid Venue Issues

North Korea's World Cup qualifying match against Qatar, set initially to be held in Pyongyang, North Korea, has been relocated to Laos.

‘Emilia Pérez,’ With 13 Oscar Nominations, to Premiere in South Korea in March

"Emilia Perez," nominated for 13 categories including Best Picture at the 97th Academy Awards, will be released on March 12.

Understanding the North Korea-Russia Alliance: Implications for Global Politics and Security

United Russia and North Korea's Workers' Party reaffirm ties, support defense measures, and oppose Western hegemony amidst global tensions.

Tag: Samsung Bioepis

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us